Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

967474

	human indexable
	published
	registered interest
	answer date	18/09/2018
	date	04/09/2018
	date tabled	04/09/2018
	ddp created	04/09/2018 20:33:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	04/09/2018 20:37:33 17/09/2018 14:40:12
	hansard heading	Prescription Drugs: Misuse
	house id	2
	identifier	HL9967
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/09/2018 14:06:06
	question text	To ask Her Majesty's Government what plans they have to secure funding for existing prescribed medicines withdrawal centres.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9967
	type	WrittenParliamentaryQuestion
	uin	HL9967
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967475

	human indexable
	published
	registered interest
	answer date	18/09/2018
	date	04/09/2018
	date tabled	04/09/2018
	ddp created	04/09/2018 20:33:04
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	04/09/2018 20:37:35 17/09/2018 14:39:04
	hansard heading	Prescription Drugs: Misuse
	house id	2
	identifier	HL9968
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/09/2018 14:06:06
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the number of prescribed medicines withdrawal centres to cover the whole of England.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9968
	type	WrittenParliamentaryQuestion
	uin	HL9968
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967476

	human indexable
	published
	registered interest
	answer date	18/09/2018
	date	04/09/2018
	date tabled	04/09/2018
	ddp created	04/09/2018 20:33:05
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	04/09/2018 20:37:37 17/09/2018 14:39:03
	hansard heading	Prescription Drugs: Misuse
	house id	2
	identifier	HL9969
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/09/2018 14:06:06
	question text	To ask Her Majesty's Government whether they will ensure that in establishing a 24 hour helpline for people affected by prescribed medicines addiction they will also ensure that adequate services are in place to refer patients to.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9969
	type	WrittenParliamentaryQuestion
	uin	HL9969
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967478

	human indexable
	published
	registered interest
	answer date	18/09/2018
	date	04/09/2018
	date tabled	04/09/2018
	ddp created	04/09/2018 20:33:08
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	04/09/2018 20:37:41 17/09/2018 14:39:01
	hansard heading	Benzodiazepines: Misuse
	house id	2
	identifier	HL9971
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/09/2018 14:06:06
	question text	To ask Her Majesty's Government whether they will establish a public inquiry into the harmful effects of prescribed benzodiazepine drug dependence over the last 50 years.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9971
	type	WrittenParliamentaryQuestion
	uin	HL9971
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947564

	human indexable
	published
	registered interest
	answer date	07/08/2018
	date	24/07/2018
	date tabled	24/07/2018
	ddp created	24/07/2018 19:09:36
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/07/2018 19:16:19 26/07/2018 13:18:02
	hansard heading	PrescQIPP
	house id	2
	identifier	HL9847
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	26/07/2018 12:46:36
	question text	To ask Her Majesty's Government what assessment they have made of the accuracy of the information provided by PrescQIPP to Clinical Commissioning Groups to aid their commissioning decisions.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9847
	type	WrittenParliamentaryQuestion
	uin	HL9847
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947566

	human indexable
	published
	registered interest
	answer date	07/08/2018
	date	24/07/2018
	date tabled	24/07/2018
	ddp created	24/07/2018 19:09:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/07/2018 19:16:21 26/07/2018 13:18:08
	hansard heading	Liothyronine
	house id	2
	identifier	HL9848
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	26/07/2018 12:46:36
	question text	To ask Her Majesty's Government what assessment they have made of whether the advice provided by PresQIPP to Clinical Commissioning Groups is consistent with national guidelines on the prescription of Liothryonine (T3) to NHS patients.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9848
	type	WrittenParliamentaryQuestion
	uin	HL9848
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947567

	human indexable
	published
	registered interest
	answer date	07/08/2018
	date	24/07/2018
	date tabled	24/07/2018
	ddp created	24/07/2018 19:09:39
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/07/2018 19:16:23 26/07/2018 13:18:13
	hansard heading	PrescQIPP
	house id	2
	identifier	HL9849
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	26/07/2018 12:46:36
	question text	To ask Her Majesty's Government what assurances they have received from PresQIPP that when providing guidance to Clinical Commissioning Groups on commissioning decisions it has taken the views of patient stakeholders into account.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL9849
	type	WrittenParliamentaryQuestion
	uin	HL9849
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931632

	human indexable
	published
	registered interest
	answer date	10/07/2018
	date	26/06/2018
	date tabled	26/06/2018
	ddp created	26/06/2018 20:17:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/06/2018 20:25:59 10/07/2018 16:13:07
	hansard heading	Liothyronine
	house id	2
	identifier	HL8980
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	10/07/2018 15:41:18
	question text	To ask Her Majesty's Government what action they propose to ensure that the Brighton and Sussex University Hospitals NHS Trust withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL8980
	type	WrittenParliamentaryQuestion
	uin	HL8980
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931633

	human indexable
	published
	registered interest
	answer date	10/07/2018
	date	26/06/2018
	date tabled	26/06/2018
	ddp created	26/06/2018 20:17:44
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/06/2018 20:26:01 10/07/2018 16:13:06
	hansard heading	Liothyronine
	house id	2
	identifier	HL8981
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	10/07/2018 15:41:18
	question text	To ask Her Majesty's Government what action they propose to take to ensure that the High Weald, Lewes and Havens Clinical Commissioning Group withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL8981
	type	WrittenParliamentaryQuestion
	uin	HL8981
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931634

	human indexable
	published
	registered interest
	answer date	10/07/2018
	date	26/06/2018
	date tabled	26/06/2018
	ddp created	26/06/2018 20:17:45
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/06/2018 20:26:03 10/07/2018 16:13:10
	hansard heading	Liothyronine
	house id	2
	identifier	HL8982
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	10/07/2018 15:41:18
	question text	To ask Her Majesty's Government what assessment they have made of the Brighton and Sussex University Hospitals NHS Trust mistakenly stating that the only option for patients wishing to continue Liothyronine (T3) therapy is through the private sector, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL8982
	type	WrittenParliamentaryQuestion
	uin	HL8982
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath